| Port-A-Cath in children during long-term chemotherapy: complications and outcome. | |
| | |
MedLine Citation:
|
PMID: 2641695 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Complications related to Port-A-Cath were studied prospectively during a period of 32 months in 31 patients, aged 1-18 years, with leukemias and solid tumors. There were 34 Port-A-Cath inserted, and the cumulative time for these catheters kept in place was 5899 days. No complications occurred in 18 patients (19 catheters) kept in place for a cumulative time of 3998 days with an average duration of 210 days (12-550 days). In 13 patients (15 catheters) there were 14 events of systemic infections; seven events were treated successfully with antibiotics, four events necessitated the extraction of the catheter (in one patient a combination of systemic and local infection), and in three events the catheters were kept unused, as the patients were in terminal stages. Nonsystemic complications occurred with five catheters; two local infections, two obstructions (catheters removed), and one local bleeding (catheter kept unused). Appropriate antimicrobial treatment of systemic infections enables the immunocompromised child to keep the Port-A-Cath in place for a long time. |
| | |
Authors:
|
M al-Hathal; G Malmfors; S Garwicz; A N Békássy |
Related Documents
:
|
941915 - Phlebitis associated with the intravenous use of cephalothin and cephapirin. 3041635 - Role of intraoperative fibrinolytic therapy in acute arterial occlusion. 17603515 - Use of totally implantable catheters for peripheral blood stem cell apheresis. 20237055 - Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization:... 8199935 - Endoscopic carpal tunnel release. 21986085 - Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pediatric hematology and oncology Volume: 6 ISSN: 0888-0018 ISO Abbreviation: Pediatr Hematol Oncol Publication Date: 1989 |
Date Detail:
|
Created Date: 1990-10-10 Completed Date: 1990-10-10 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8700164 Medline TA: Pediatr Hematol Oncol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 17-22 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, University Hospital, Lund, Sweden. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Antineoplastic Agents / administration & dosage* Catheterization, Central Venous / adverse effects* Child Child, Preschool Cloxacillin / therapeutic use Hematoma / etiology Humans Infant Neoplasms / drug therapy* Sepsis / etiology, prevention & control |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 61-72-3/Cloxacillin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reduced leucine catabolism induced by chemotherapy in leukemic children.
Next Document: Juvenile chronic myelogenous leukemia and neurofibromatosis in infancy presenting as ocular hemorrha...